Improve walking reduce caregiver burden
- Trial ID
- NCT06892717
- Official Title
- Caregiver Burden and Associated Factors in Parkinson's Disease
- Goal
- Improve walking reduce caregiver burden
- Status
- RECRUITING
- Sponsor
- Beylikduzu State Hospital
- Study Type
- OBSERVATIONAL
- Enrollment
- 43 participants
- Conditions
- Parkinson Disease
- Interventions
Plain-Language Summary
The goal is to measure caregiver burden and identify which patient and caregiver factors, like Parkinson's severity and daily care needs, are linked to higher stress, fatigue, or reduced quality of life for unpaid family caregivers. The study is observational, collecting information from patients and their informal caregivers using interviews, questionnaires, and routine clinical data to quantify burden and relate it to disease stage and care requirements. They are looking for people 40 to 80 years old with Parkinson's at Hoehn and Yahr stage 2 to 5 who need help with daily activities and who have an unpaid caregiver fluent in Turkish; people with other neurodegenerative diseases, active cancer, severe heart failure, COPD, stroke-related limitations, or immobility for reasons other than Parkinson's are excluded.
Locations
- Beylikdüzü State Hospital, Istanbul, Beylikdüzü, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The goal is to measure caregiver burden and identify which patient and caregiver factors, like Parkinson's severity and daily care needs, are linked to higher stress, fatigue, or reduced quality of life for unpaid family caregivers. The study is observational, collecting information from patients and their informal caregivers using interviews, questionnaires, and routine clinical data to quantify burden and relate it to disease stage and care requirements. They are looking for people 40 to 80 years old with Parkinson's at Hoehn and Yahr stage 2 to 5 who need help with daily activities and who have an unpaid caregiver fluent in Turkish; people with other neurodegenerative diseases, active cancer, severe heart failure, COPD, stroke-related limitations, or immobility for reasons other than Parkinson's are excluded.
- Who can participate?
- Participants must be between 40 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 months.